Market News

Monday’s ETF with Unusual Volume: IMCB

The iShares Morningstar Mid-Cap ETF is seeing unusually high volume in afternoon trading Monday, with over 254,000 shares traded versus three month average volume of about 39,000. Shares of IMCB were trading flat on the day. Components of that ETF with the highest volume on …

Read more

3 Chinese Stocks I Own in 2025

If you’ve made it this far, you’ve passed the test. Chinese stocks aren’t very popular with stateside investors these days. With tariffs about to muddy up a trade war and TikTok’s ban hanging in the balance, it’s easy to sidestep exposure to China when there’s …

Read more

Revolutionizing Home Care: AlayaCare Launches Layla, an AI-Powered Assistant

NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) — AlayaCare, a leading provider of cloud-based home care solutions, is proud to announce the launch of Layla, an AI-powered conversational agent designed to revolutionize home-based care delivery. Integrated seamlessly within the AlayaCare platform, Layla provides caregivers and …

Read more

New Strong Buy Stocks for January 17th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Rigel Pharmaceuticals RIGL: This clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases, has seen the Zacks Consensus Estimate …

Read more

Direxion’s Micron Bull And Bear ETFs Allow Investors To Trade The Tech Tug-of-War – Micron Technology (NASDAQ:MU), Direxion Daily MU Bear 1X Shares (NASDAQ:MUD)

Artificial intelligence quite evidently seems to have been a growth driver for computer memory and data storage specialist Micron Technology Inc MU. Throughout the first half of last year, MU stock shot skyward, at one point exceeding $150 per share. However, starting from the back …

Read more

Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit – Kyverna Therapeutics (NASDAQ:KYTX)

LOS ANGELES, Jan. 14, 2025 /PRNewswire/ — Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) KYTX. IF YOU SUFFERED A LOSS ON YOUR KYVERNA INVESTMENTS, …

Read more

5 Reasons to Be Bullish on Stocks in Early 2025

Though 2025 has barely started, it’s off to a bumpy and choppy start. However, several data points suggest that the multi-year bull market in stocks will continue, and bulls should stay the course. Below are five bullish catalysts for US equities: 1. Easing Geopolitical Tensions …

Read more

1 Hypergrowth Tech Stock to Buy in 2025

It never hurts to plan ahead. One of the greatest hypergrowth stocks on the market is a terrible buy right now, but that should change in 2025. An overheated stock price should cool down in the next few months, while the underlying long-term success story …

Read more

Got $5,000? 3 Tech Stocks to Buy and Hold for the Long Term

Putting $5,000 into a handful of stocks gives you a lot of potential for future gains if you find the right companies to invest in. Thankfully, plenty of fantastic tech stocks are tapping into growing trends that could be winners over the long term. Here’s …

Read more

Earnings Preview: What To Expect From Hologic’s Report

With a market cap of $15.9 billion, Marlborough, Massachusetts-based Hologic, Inc. (HOLX) specializes in developing, manufacturing, and supplying diagnostics, medical imaging systems, and surgical products aimed at advancing women’s healthcare. Operating across Diagnostics, Breast Health, GYN Surgical, and Skeletal Health segments, the company provides innovative solutions …

Read more